RxE2

Bringing the practice of pharmacy into clinical research

08/13/2026

Patient retention and protocol adherence are two of the greatest challenges in the clinical research industry. When patients fail to take medication as directed, it compromises the entire data set and can delay the approval of new treatments. Pharmacists are uniquely qualified to address this issue through their existing expertise in adherence support. By providing the coaching and education needed to keep participants on track, pharmacies ensure high levels of protocol fidelity. This strength makes community pharmacies indispensable partners in the development of new medical breakthroughs.

08/11/2026

The landscape of community pharmacy is undergoing a fundamental shift as reimbursement models for traditional dispensing continue to tighten. Many independent pharmacies are diversifying their revenue by integrating advanced clinical services like research into their practice. This evolution allows pharmacists to be recognized and compensated for their clinical expertise rather than just the products they provide. Moving toward clinical research integration provides a professional revenue stream that is not tied to dispensing margins. It ensures that the pharmacy remains a viable and essential part of the healthcare ecosystem for years to come.

08/06/2026

Decentralized clinical trials are changing how research is conducted by removing the requirement for patients to travel to distant academic centers. The satellite site model allows local pharmacies to serve as clinical research hubs within their own communities. Under this framework, pharmacies handle the patient-facing clinical work while leveraging the infrastructure of a central research organization. This model reduces the burden on patients and makes clinical research a more accessible part of local healthcare. It represents the future of a more inclusive and efficient research enterprise.

08/04/2026

The healthcare industry is shifting toward continuous monitoring to improve patient outcomes and gather real-world data. For pharmacies, remote patient monitoring represents a natural expansion of their role as clinical leaders. By overseeing patient data from wearable devices and digital tools, pharmacists can provide more timely interventions. This approach moves the pharmacy from a reactive model to a proactive one. It ensures that clinical trials and standard care are informed by real-time health metrics rather than periodic visits.

07/30/2026

When new health threats emerge, the speed of vaccine development and testing is critical. Community pharmacies have proven their ability to mobilize quickly for large scale vaccination efforts. By applying these same frameworks to clinical research, pharmacies can accelerate the recruitment process for new vaccine trials. This rapid response capability is a cornerstone of a modern and resilient research infrastructure.

07/28/2026

Many dermatology trials rely on frequent visual assessments that can be burdensome for patients to attend at distant sites. Community pharmacies can simplify this process by hosting these assessments locally. Since pharmacists already see patients for various skin treatments, they can easily monitor progress and document changes as part of a clinical trial protocol. This localized care model increases patient retention and ensures high quality data for new dermatological therapies.

07/23/2026

Research into mental health and central nervous system disorders requires a high level of trust and a supportive environment. Patients often feel more comfortable discussing these sensitive topics with a pharmacist they have known for years. By providing a private space for these clinical interactions, pharmacies can help reduce the stigma associated with these trials. This patient centered approach is vital for advancing new treatments in behavioral and neurological health.

07/21/2026

Chronic obstructive pulmonary disease often goes undiagnosed until it reaches an advanced stage. Community pharmacies are ideally positioned to help identify these patients early through routine screenings and inhaler consultations. By integrating respiratory research into these existing interactions, pharmacies can provide patients with early access to new therapies. This proactive approach helps clinical trials reach the right participants while improving long term outcomes for the local community.

07/16/2026

The next few years will see a significant increase in clinical trials for oral GLP-1 medications. As these treatments move from injections to oral forms, the community pharmacy becomes the natural site for patient identification and monitoring. Pharmacists are already on the front lines of metabolic health and can offer the consistent support these trials require. This wave of research represents a major opportunity to integrate weight management services with clinical research in a familiar setting.

07/14/2026

Heart health remains a top priority in clinical research, but many hypertension studies struggle to reach the populations most affected. By bringing these trials into the community pharmacy setting, research becomes accessible to patients who may not visit large academic medical centers. Pharmacists already manage blood pressure for many of these individuals and can provide the education needed to bridge the gap in care. This local access is a key factor in developing more effective treatments for diverse populations.

Address

4302 13th Avenue S Suite 4326
Fargo, ND
58103

Website

https://www.rxe2.com/

Alerts

Be the first to know and let us send you an email when RxE2 posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to RxE2:

Want your business to be the top-listed Health & Beauty Business in Fargo?